Phil Lorenzi PhD
Assoc. Prof., Dir. of Metabolomics Core, Dir. of Proteomics Core, MD Anderson Cancer Center
Dr. Lorenzi is the Director of the Metabolomics Core Facility, Director of the Proteomics Core Facility, and Associate Professor in the Department of Bioinformatics and Computational Biology at The University of Texas MD Anderson Cancer Center.
His background and training are in chemistry, pharmacology, and omic technologies (genomics, transcriptomics, proteomics, and metabolomics). His laboratory develops metabolic therapies for the treatment of cancer.
He collaborates with 200+ investigators per year on projects that span the continuum of drug development and life science research, and has co-authored 94 peer-reviewed publications. His multidisciplinary team provides analytical services in a state-of-the art facility